Medically reviewed by Dr. Magnus Jayaraj Mansard, Specialist in Liver Transplantation, HPB Surgery and Surgical Gastroenterology. Last medically reviewed on October 2026
Non-alcoholic fatty liver disease (NAFLD) is a condition in which excess fat builds up in the liver without alcohol being the main cause. The condition is now commonly called metabolic dysfunction-associated steatotic liver disease (MASLD). It is often associated with excess weight, insulin resistance, type 2 diabetes, high cholesterol, high blood pressure and other metabolic conditions.
Fatty liver may not cause noticeable symptoms in the early stages. However, some people can develop inflammation and liver scarring over time. The good news is that early-stage fatty liver can often be improved with appropriate lifestyle changes and medical care.
Non alcoholic fatty liver disease treatment depends on the amount of fat in the liver, the presence of inflammation, the degree of fibrosis or scarring, and a person’s overall metabolic health.
What is MASLD?
MASLD is the newer medical term used for fatty liver disease associated with metabolic dysfunction. It develops when excess fat accumulates in the liver in association with metabolic risk factors.
These may include:
- Overweight or obesity
- Type 2 diabetes or insulin resistance
- High cholesterol or triglycerides
- High blood pressure
- Increased abdominal fat
- A sedentary lifestyle
- An unhealthy dietary pattern
MASLD can range from simple liver fat accumulation to a more advanced form called metabolic dysfunction-associated steatohepatitis (MASH).
MASH involves liver inflammation and can cause progressive fibrosis. Advanced fibrosis may eventually lead to cirrhosis and liver-related complications.
What are the symptoms of fatty liver disease?
Many people with MASLD have no symptoms, especially during the early stages. Fatty liver is sometimes discovered during a routine health check, blood test or abdominal ultrasound.
When symptoms occur, they may include:
- Tiredness or low energy
- A feeling of discomfort in the upper-right abdomen
- General weakness
- Symptoms related to diabetes or metabolic problems
Symptoms alone cannot determine how severe fatty liver disease is. A person may have few symptoms despite having significant fibrosis. Therefore, appropriate medical evaluation is important when fatty liver is identified.
What causes non-alcoholic fatty liver disease?
Fatty liver usually develops through a combination of metabolic, lifestyle and genetic factors.
Common contributors include:
- Excess body weight: Extra body fat, particularly around the abdomen, is strongly associated with fatty liver. Improving body composition and achieving sustainable weight loss can reduce liver fat.
- Insulin resistance and diabetes: Insulin resistance can increase the movement of fatty acids into the liver and contribute to liver fat accumulation. People with type 2 diabetes have a higher risk of developing progressive fatty liver disease.
- High cholesterol and triglycerides: Abnormal blood lipid levels may contribute to metabolic dysfunction and are important to address as part of overall treatment.
- Unhealthy dietary patterns: Frequent consumption of sugary beverages, highly processed foods, excess calories and foods high in saturated fat can contribute to metabolic problems and liver fat accumulation.
- Physical inactivity: A sedentary lifestyle can worsen insulin resistance and make weight management more difficult.
How is fatty liver disease diagnosed?
A diagnosis should not rely on an ultrasound report alone. Doctors may use a combination of medical history, blood tests, imaging and fibrosis-risk assessment.
Common evaluations include:
- Liver function tests
- Blood glucose and HbA1c
- Cholesterol and triglyceride testing
- Abdominal ultrasound
- Fibrosis assessment
- FIB-4 calculation
- Transient elastography or FibroScan when appropriate
- Additional tests to exclude other causes of liver disease
A liver enzyme level that is within the normal range does not always mean that significant liver disease is absent. The degree of fibrosis is particularly important when assessing long-term risk.
What is FIB-4 and why is it important?
FIB-4 is a non-invasive calculation that uses factors including age, AST, ALT and platelet count to estimate the likelihood of advanced liver fibrosis.
It can help doctors decide whether a person requires additional assessment.
For example, AASLD guidance uses FIB-4 as an initial risk assessment tool. In many adults, a FIB-4 below 1.3 suggests a lower likelihood of advanced fibrosis, while higher results may require further assessment such as elastography or specialist evaluation. Age and clinical circumstances need to be considered when interpreting the result.
FIB-4 is a risk-assessment tool, not a diagnosis. It should be interpreted by a healthcare professional along with the person’s age, medical history, laboratory results and other findings.
What is the treatment for non-alcoholic fatty liver disease?
There is no single treatment that is appropriate for every person with fatty liver disease.
Treatment generally focuses on:
- Reducing liver fat
- Improving metabolic health
- Preventing or slowing fibrosis
- Treating associated conditions
- Identifying people at higher risk of complications
1. Gradual and sustainable weight management
For people who are overweight or have obesity, gradual weight loss can significantly improve fatty liver.
Even modest weight loss can reduce liver fat. Greater sustained weight loss may provide additional benefits for liver inflammation and fibrosis. Current European guidance suggests aiming for at least 5% sustained weight reduction to reduce liver fat, 7–10% to improve liver inflammation, and more than 10% when the goal is to improve fibrosis, where appropriate.
The target should be individualized rather than based on a one-size-fits-all plan.
Rapid or extreme dieting is generally not the goal. A sustainable eating and activity plan is more useful for long-term liver health.
2. Follow a liver-friendly eating pattern
A healthy dietary pattern is an important part of MASLD management.
Rather than focusing on a single “fatty liver food,” aim for an overall balanced diet containing:
- Vegetables
- Whole fruits
- Whole grains
- Pulses and legumes
- Appropriate portions of protein
- Nuts and seeds
- Healthy unsaturated fats
It is also helpful to reduce:
- Sugar-sweetened beverages
- Excess added sugar
- Highly processed foods
- Excess saturated fat
- Large portions
- Frequent high-calorie snacks
Guidelines support improving overall diet quality and reducing ultra-processed foods and sugar-sweetened beverages.
For Indian patients, dietary advice should ideally be adapted to familiar foods, meal timings, cultural preferences and individual metabolic conditions rather than recommending a generic Western diet.
3. Exercise regularly
Physical activity can improve liver fat and metabolic health, even when significant weight loss does not occur.
A combination of aerobic activity and resistance training can be useful. Depending on fitness and medical conditions, activities may include:
- Brisk walking
- Cycling
- Swimming
- Jogging
- Strength training
- Other enjoyable forms of regular physical activity
Current guidance generally supports around 150 minutes of moderate-intensity physical activity per week for many adults, with the exact plan adjusted to individual ability and health status. If you have not exercised regularly, start gradually and increase activity over time.
4. Manage diabetes and insulin resistance
Good control of blood glucose is an important part of fatty liver management.
If you have diabetes, prediabetes or insulin resistance, your doctor may recommend dietary changes, exercise, weight management and appropriate medication.
Some medicines used for diabetes or obesity may also have benefits for people with MASLD. However, medication decisions should be based on the individual’s diagnosis, weight, diabetes status, liver disease severity and other health conditions.
5. Manage cholesterol and blood pressure
MASLD is closely associated with cardiometabolic health.
Managing:
- LDL cholesterol
- Triglycerides
- Blood pressure
- Blood glucose
- Body weight
can form an important part of overall treatment. The aim is not simply to treat the liver in isolation. Improving metabolic and cardiovascular health is an important part of managing fatty liver disease.
Are medicines used to treat fatty liver disease?
Medication is not required for everyone with fatty liver.
Some medicines may be considered when a person has diabetes, obesity or other metabolic conditions. In selected patients with non-cirrhotic MASH and significant fibrosis, specialist-directed liver-specific treatment may also be considered where approved and appropriate.
AASLD has published updates concerning therapies such as resmetirom and semaglutide, reflecting the rapidly developing treatment landscape.
Because treatment eligibility depends on disease stage and individual health factors, patients should not start liver medications, supplements or herbal products without medical advice.
Some supplements marketed as “liver detox” or “fatty liver cures” may not have reliable evidence and some herbal products can cause liver injury.
Can fatty liver be reversed?
Early fatty liver can often improve substantially when the underlying metabolic factors are addressed.
Reducing liver fat through sustainable lifestyle changes may improve liver health. Greater weight loss can provide greater benefits in appropriate patients, particularly when inflammation or fibrosis is present.
However, the possibility of reversal depends on the stage of disease.
Simple steatosis, MASH and advanced fibrosis are not the same condition. Someone with significant fibrosis or cirrhosis needs medical monitoring even if liver enzymes improve. This is why identifying the degree of fibrosis is an important part of fatty liver management.
When should you see a liver specialist?
Consider medical evaluation if:
- An ultrasound shows fatty liver
- Liver enzymes are repeatedly abnormal
- You have type 2 diabetes and fatty liver
- You have obesity with other metabolic risk factors
- You have high triglycerides or cholesterol
- You have a family history of significant liver disease
- A fibrosis score is elevated
- FibroScan or other imaging suggests fibrosis
- You have symptoms or signs of advanced liver disease
A gastroenterologist or hepatologist can assess the cause of liver fat, estimate the risk of fibrosis and recommend an appropriate follow-up plan.
Can fatty liver lead to cirrhosis?
Not everyone with fatty liver develops cirrhosis.
However, some people develop MASH with progressive fibrosis. Advanced fibrosis can eventually progress to cirrhosis and increase the risk of liver-related complications.
The risk is influenced by factors such as diabetes, obesity, metabolic health and the existing degree of liver fibrosis. This is why finding fatty liver should not simply be dismissed as an incidental ultrasound finding. Appropriate risk assessment can help identify people who need closer monitoring.
Takeaway
Non-alcoholic fatty liver disease, now commonly called MASLD, is closely connected with metabolic health. Treatment is not simply about reducing liver fat; it is about addressing the factors that contribute to liver disease and identifying people at risk of fibrosis.
For many patients, sustainable weight management, a balanced diet, regular exercise and control of diabetes, cholesterol and blood pressure form the foundation of treatment. Some patients require additional investigation or specialist treatment depending on the degree of liver inflammation and fibrosis.
If you have been diagnosed with fatty liver, an appropriate medical assessment can help determine your disease stage and create a treatment and monitoring plan suited to your individual needs.
Read Also: Liver Transplant Success Rate in India
